More hospitals use Cerner than Epic to attest to Medicare’s EHR Incentive Program

Hospitals and health systems were  slightly more likely to use Cerner’s 2015 Certified EHR Technology than Epic’s when attesting to Medicare’s EHR Incentive Program between 2011 and 2016, according to recently released data from HHS’ ONC.

Advertisement

However, eligible clinicians were  more likely to use Epic’s 2015 CEHRT than Cerner’s to attest to the Medicare EHR Incentive Program between 2011 and 2016.

To compile its datasets, ONC reviewed a subset of 2015 CEHRT criteria necessary to meet the “Base EHR definition.” The agency then matched health IT developers with CMS data on Medicare EHR Incentive Program attestations to estimate the proportion of healthcare providers that use a developer’s CEHRT. This allowed ONC to approximate the share of users on each CEHRT.

Here are the top five vendors used by eligible hospitals.

  1. Cerner (23.73 percent)
  2. Epic (22.14 percent)
  3. Allscripts (5.37 percent)
  4. GE Healthcare (0.51 percent)
  5. Medsphere Systems (0.22 percent)

Here are the top five vendors used by eligible clinicians.

  1. Epic (27.29 percent)
  2. ALlscripts (9.51 percent)
  3. eClinicalWorks (7.46 percent)
  4. NextGen Healthcare (5.48 percent)
  5. GE Healthcare (5.16 percent)

More articles on EHRs:

Why the VA’s EHR project may top $16B
HIMSS voices support for VA proposal to ease requirements for medical record sharing
16 hospitals, health systems seeking Allscripts, Cerner, Epic, Meditech talent

 

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in EHRs / Interoperability

Advertisement

Comments are closed.